Abstract
We studied the pharmacokinetics of erythromycin estolate and ethylsuccinate suspensions in infants under 4 months of age who were being treated for chlamydial infections or pertussis. We conducted our studies after the initial dose of 10 mg/kg and subsequently during steady-state treatment. The estolate preparation resulted in higher peak concentrations in sera, and its absorption and elimination half-lives were longer. Peak concentrations occurred 3 h after a dose with the estolate preparation and 1 h after a dose with the ethylsuccinate preparation. The area under the curve for the estolate preparation was about three times greater than that for the ethylsuccinate preparation. Based on these findings, we recommend that erythromycin estolate suspensions be given to young infants at 8- or 12-h intervals (30 mg/kg per day in three divided doses or 20 mg/kg per day in two divided doses) and that erythromycin ethylsuccinate is best given at 6-h intervals (40 mg/kg per day in four divided doses).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BURNS L., HODGMAN J. STUDIES OF PREMATURES GIVEN ERYTHROMYCIN ESTOLATE. Am J Dis Child. 1963 Sep;106:280–288. doi: 10.1001/archpedi.1963.02080050282005. [DOI] [PubMed] [Google Scholar]
- DiSanto A. R., Tserng K. Y., Chodos D. J., DeSante K. A., Albert K. S., Wagner J. G. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets. J Clin Pharmacol. 1980 Jul;20(7):437–443. doi: 10.1002/j.1552-4604.1980.tb01716.x. [DOI] [PubMed] [Google Scholar]
- FORFAR J. O., MACCABE A. F. Erythromycin--a review. Antibiot Chemother. 1957;4:115–157. doi: 10.1159/000386635. [DOI] [PubMed] [Google Scholar]
- Ginsburg C. M., Eichenwald H. F. Erythromycin: a review of its uses in pediatric practice. J Pediatr. 1976 Dec;89(6):872–884. doi: 10.1016/s0022-3476(76)80590-2. [DOI] [PubMed] [Google Scholar]
- Kuo C. C., Wang S. P., Grayston J. T. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother. 1977 Jul;12(1):80–83. doi: 10.1128/aac.12.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCracken G. H., Jr, Ginsburg C. M., Clahsen J. C., Thomas M. L. Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability. Pediatrics. 1978 Nov;62(5):738–743. [PubMed] [Google Scholar]
- Simon H. J., Yin E. J. Microbioassay of antimicrobial agents. Appl Microbiol. 1970 Apr;19(4):573–579. doi: 10.1128/am.19.4.573-579.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tardrew P. L., Mao J. C., Kenney D. Antibacterial activity of 2'-esters of erythromycin. Appl Microbiol. 1969 Aug;18(2):159–165. doi: 10.1128/am.18.2.159-165.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]